Cite
HARVARD Citation
Sun, H. et al. (2021). A case report of response to crizotinib in chemotherapy-refractory metastatic gallbladder cancer with met amplification and acquired resistance resulting from the loss of MET amplification. Precision clinical medicine. 4 (3), pp. 209-214. [Online].